Anti-SMAD6 antibody (323-372 aa) (STJ95703)
SPECIFICATIONS
ClonalityPolyclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenThe antiserum was produced against synthesized peptide derived from the human Smad6 at the amino acid range 323-372
General Information
| Short Description | Rabbit polyclonal anti-Mothers against decapentaplegic homolog 6 (323-372 aa) for use in WB, IHC, IF and ELISA in Human and Mouse samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | WB/IHC/IF/ELISA |
| Host | Rabbit |
| Reactivity | Human/Mouse |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Polyclonal |
| Isotype | IgG |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Dilution Range | WB 1:500-1:2000IHC 1:100-1:300ELISA 1:40000IF 1:50-200 |
| Formulation | Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Target Information
| Gene Symbol | SMAD6 |
| Gene ID | 4091 |
| Uniprot ID | SMAD6_HUMAN |
| Immunogen | The antiserum was produced against synthesized peptide derived from the human Smad6 at the amino acid range 323-372 |
| Immunogen Region | 323-372 aa |
| Specificity | Smad6 Polyclonal Antibody detects endogenous levels of Smad6 protein. |
Additional Info
| Post Translational Modifications | Phosphorylated by BMP type 1 receptor kinase and by PRKX. Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation. Ubiquitinated by WWP1. Ubiquitinated by ARK2C, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling. Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling. |
| Function | Transforming growth factor-beta superfamily receptors signaling occurs through the Smad family of intracellular mediators. SMAD6 is an inhibitory Smad (i-Smad) that negatively regulates signaling downstream of type I transforming growth factor-beta. Acts as a mediator of TGF-beta and BMP anti-inflammatory activities. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of pro-inflammatory genes. Blocks the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding. Binds to regulatory elements in target promoter regions. |
| Protein Name | Mothers Against Decapentaplegic Homolog 6Mad Homolog 6Mothers Against Dpp Homolog 6Smad Family Member 6Smad 6Smad6Hsmad6 |
| Database Links | Reactome: R-HSA-201451Reactome: R-HSA-8941326 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Mothers Against Decapentaplegic Homolog 6 antibodyAnti-Mad Homolog 6 antibodyAnti-Mothers Against Dpp Homolog 6 antibodyAnti-Smad Family Member 6 antibodyAnti-Smad 6 antibodyAnti-Smad6 antibodyAnti-Hsmad6 antibodyAnti-SMAD6 antibodyAnti-MADH6 antibody |
Information sourced from Uniprot.org